These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8369987)

  • 21. Changes in bone metabolism during treatment of acromegaly.
    Bijlsma JW; Nortier JW; Duursma SA; Croughs RJ; Bosch R; Thijssen JH
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):153-9. PubMed ID: 6688910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone isoenzyme of serum alkaline phosphatase in acromegaly.
    Stĕpán J; Marek J; Havránek T; Dolezal V; Pacovský V
    Clin Chim Acta; 1979 May; 93(3):355-63. PubMed ID: 36248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a growth hormone receptor antagonist on bone markers in acromegaly.
    Fairfield WP; Sesmilo G; Katznelson L; Pulaski K; Freda PU; Stavrou S; Kleinberg D; Klibanski A
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):385-90. PubMed ID: 12201832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group.
    Murphy MG; Bach MA; Plotkin D; Bolognese J; Ng J; Krupa D; Cerchio K; Gertz BJ
    J Bone Miner Res; 1999 Jul; 14(7):1182-8. PubMed ID: 10404019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function.
    Bolanowski M; Daroszewski J; Medraś M; Zadrozna-Sliwka B
    J Bone Miner Metab; 2006; 24(1):72-8. PubMed ID: 16369902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults.
    Johansen JS; Pedersen SA; Jørgensen JO; Riis BJ; Christiansen C; Christiansen JS; Skakkebaek NE
    J Clin Endocrinol Metab; 1990 Apr; 70(4):916-9. PubMed ID: 2180981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.
    Ueland T; Fougner SL; Godang K; Schreiner T; Bollerslev J
    Eur J Endocrinol; 2006 Nov; 155(5):709-15. PubMed ID: 17062887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum osteocalcin or bone Gla-protein, a biochemical marker for bone metabolism in horses: differences in serum levels with age.
    Lepage OM; Marcoux M; Tremblay A
    Can J Vet Res; 1990 Apr; 54(2):223-6. PubMed ID: 2357658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-like growth factor 1 and bone turnover in glucocorticoid-treated and control subjects.
    Reid IR; Gluckman PD; Ibbertson HK
    Clin Endocrinol (Oxf); 1989 Apr; 30(4):347-53. PubMed ID: 2598471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism.
    Minisola S; Scarnecchia L; Carnevale V; Bigi F; Romagnoli E; Pacitti MT; Rosso R; Mazzuoli GF
    J Endocrinol Invest; 1989 Sep; 12(8):537-42. PubMed ID: 2592739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
    Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
    J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome.
    Piovesan A; Terzolo M; Reimondo G; Pia A; Codegone A; Osella G; Boccuzzi A; Paccotti P; Angeli A
    Horm Metab Res; 1994 May; 26(5):234-7. PubMed ID: 8076906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
    Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
    Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
    Skjaerbaek C; Frystyk J; Kaal A; Laursen T; Møller J; Weeke J; Jørgensen JO; Sandahl Christiansen J; Orskov H
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):25-33. PubMed ID: 10651750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone properties in patients with acromegaly: quantitative ultrasound of the heel.
    Kastelan D; Dusek T; Kraljevic I; Polasek O; Perkovic Z; Kardum I; Giljevic Z; Jelcic J; Aganovic I; Korsic M
    J Clin Densitom; 2007; 10(3):327-31. PubMed ID: 17543559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone turnover markers in tumor pathology with bone involvement].
    Napal Lecumberri J; Amado Señarís JA; Pesquera C; Riancho JA; González Macías J
    Med Clin (Barc); 1990 Apr; 94(13):487-9. PubMed ID: 2355762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
    Juul A; Main K; Blum WF; Lindholm J; Ranke MB; Skakkebaek NE
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals.
    van Kesteren P; Lips P; Deville W; Popp-Snijders C; Asscheman H; Megens J; Gooren L
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2227-32. PubMed ID: 8964856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
    Kim HJ; Kwon SH; Kim SW; Park DJ; Shin CS; Park KS; Kim SY; Cho BY; Lee HK
    Horm Res; 2001; 56(3-4):117-23. PubMed ID: 11847474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.